HDT Bio Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
55
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1M
- Investors
-
7
HDT Bio General Information
Description
Operator of a clinical-stage company intended to develop ribonucleic-based vaccines and therapeutics for infectious disease and oncology. The company's formulation technology specializes in stabilizing and delivering nucleic acids via multiple routes of administration with enhanced thermostability and lyophilization product lines, including self-amplifying Ribonucleic vaccines and innate immune agonist therapeutics, enabling healthcare systems to address the critical unmet needs in treating cancers and infectious diseases across the globe.
Contact Information
Website
www.hdt.bioCorporate Office
- 1150 Eastlake Avenue East
- Suite 200A
- Seattle, WA 98109
- United States
Corporate Office
- 1150 Eastlake Avenue East
- Suite 200A
- Seattle, WA 98109
- United States
HDT Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Grant | 04-Oct-2023 | $1M | Completed | Clinical Trials - Phase 1 | ||
| 7. Early Stage VC (Series A) | 13-Jun-2022 | Cancelled | Clinical Trials - Phase 1 | |||
| 6. Seed Round | 13-Oct-2022 | Completed | Clinical Trials - Phase 1 | |||
| 5. Grant | 10-May-2022 | Completed | Clinical Trials - Phase 1 | |||
| 4. Grant | 22-Apr-2022 | Completed | Clinical Trials - Phase 1 | |||
| 3. Seed Round | 05-Oct-2020 | Completed | Pre-Clinical Trials | |||
| 2. Grant | 01-Sep-2020 | $8.2M | Completed | Pre-Clinical Trials | ||
| 1. Grant | 01-Jan-2019 | $1.05M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
HDT Bio Comparisons
Industry
Financing
Details
HDT Bio Competitors (3)
One of HDT Bio’s 3 competitors is Moderna, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Moderna | Formerly VC-backed | Cambridge, MA | ||||
| BioNTech | Formerly VC-backed | Mainz, Germany | ||||
| Arcturus Therapeutics Holdings | Formerly VC-backed | San Diego, CA |
HDT Bio Patents
HDT Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026221982-A2 | Nanoparticle and non-coding rna compositions | Pending | 14-Apr-2025 | ||
| WO-2025184356-A1 | Vaccines and compositions against gamma herpesviruses | Pending | 28-Feb-2024 | ||
| EP-4791437-A1 | Junction opener protein and nanoparticle compositions and uses thereof | Pending | 12-Oct-2023 | ||
| WO-2025081013-A1 | Junction opener protein and nanoparticle compositions and uses thereof | Inactive | 12-Oct-2023 | ||
| AU-2024206838-A1 | Nanoparticle complexes for enhanced safety | Pending | 06-Jan-2023 | A61K39/12 |
HDT Bio Signals
HDT Bio Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BARDA | Government | |||
| Johnson & Johnson Innovation - JLABS | Accelerator/Incubator | |||
| National Institutes of Health | Government | Minority | ||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority |
HDT Bio FAQs
-
When was HDT Bio founded?
HDT Bio was founded in 2018.
-
Where is HDT Bio headquartered?
HDT Bio is headquartered in Seattle, WA.
-
What is the size of HDT Bio?
HDT Bio has 55 total employees.
-
What industry is HDT Bio in?
HDT Bio’s primary industry is Biotechnology.
-
Is HDT Bio a private or public company?
HDT Bio is a Private company.
-
What is HDT Bio’s current revenue?
The current revenue for HDT Bio is .
-
How much funding has HDT Bio raised over time?
HDT Bio has raised $14.5M.
-
Who are HDT Bio’s investors?
BARDA, Johnson & Johnson Innovation - JLABS, National Institutes of Health, , and are 5 of 7 investors who have invested in HDT Bio.
-
Who are HDT Bio’s competitors?
Moderna, BioNTech, and Arcturus Therapeutics Holdings are competitors of HDT Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process